姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Huang,Chong-Ren | Chairman | 5.72% | Quantum Vision Corporation |
Lu,Shu-Dong | Director | 5.72% | Quantum Vision Corporation |
Lin,Rong-Sheng | Director | 11.93% | Li Hsin Investment Corp. |
Hong,Zhi-Xian | Director | 11.93% | Li Hsin Investment Corp. |
Chen,Ji-Yuan | Director | 3.03% | SYNAGE TECHNOLOGY CORPORATION |
Jiang,Tian-Hong | Director | 0.73% | MOLECATEX INC. |
Chen,Shi-Xian | Director | 14.84% | NATIONAL DEVELOPMENT FUND MANAGEMENT COMMITTEE, EXECUTIVE YUAN |
Yang,Hong-Ze | Director | 14.84% | NATIONAL DEVELOPMENT FUND MANAGEMENT COMMITTEE, EXECUTIVE YUAN |
Liu,Su-Qing | Director | 13.09% | Aerospace Industrial Development Corporation |
Huang,Xiu-Yan | Director | 13.09% | Aerospace Industrial Development Corporation |
Li,Zhong-Liang | Director | 4.36% | Collins Co., Ltd. |
Huang,Jun-Qin | Supervisor | 1.64% | NOVAX TECHNOLOGIES, INC. |
Zhang,Yi-Zhong | Supervisor | 0.73% | ZHI LI INVESTMENT CO., LTD. |
Huang,Chong-Heng | Supervisor | 5.04% | ZHI LI INVESTMENT CO., LTD. |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Operating income | 88,684 | 82,618 | 123,866 |
Operating cost | 61,332 | 68,801 | 83,766 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 27,352 | 13,817 | 40,100 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 27,352 | 13,817 | 40,100 |
Operating expenses | 60,219 | 52,964 | 62,652 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | -32,867 | -39,147 | -22,552 |
Non-operating income and expenses | 6,609 | 13,232 | 23,553 |
Net profit (loss) before tax | -26,258 | -25,915 | 1,001 |
Income tax expense (benefits) | 0 | 0 | 0 |
Net profit (loss) of ongoing business for the current period | -26,258 | -25,915 | 1,001 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | -26,258 | -25,915 | 1,001 |
Other comprehensive profit (loss), net | -1,799 | -3,390 | -55,408 |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | -28,057 | -29,305 | -54,407 |
Net profit (loss) attributable to owners of parent company | - | - | - |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | 0 | 0 | 0 |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | - | - | - |
Net cash inflows (outflows) from investing activities | - | - | - |
Net cash inflow (outflow) from financing activities | - | - | - |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
Beginning balance of cash and cash equivalents | - | - | - |
Ending balance of cash and cash equivalents | - | - | - |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Current asset | 236,623 | 247,213 | 271,361 |
Non-current asset | 79,543 | 100,444 | 107,066 |
Total asset | 316,166 | 347,657 | 378,427 |
Current liability | 26,741 | 29,564 | 30,416 |
Non-current liability | 21,883 | 22,494 | 23,107 |
Total liability | 48,624 | 52,058 | 53,523 |
share capital | 379,405 | 379,405 | 379,405 |
Equity - secruity token | - | - | - |
capital reserve | 816 | 816 | 816 |
retained earning | -96,976 | -86,034 | -59,838 |
Other equity | -15,703 | 1,412 | 4,521 |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | - | - | - |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 267,542 | 295,599 | 324,904 |
Share capital awaiting retirement (unit: share) | - | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 7 | 7 | 8 |